210 related articles for article (PubMed ID: 18302020)
1. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
Swain SM; Land SR; Ritter MW; Costantino JP; Cecchini RS; Mamounas EP; Wolmark N; Ganz PA
Breast Cancer Res Treat; 2009 Jan; 113(2):315-20. PubMed ID: 18302020
[TBL] [Abstract][Full Text] [Related]
2. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
Ganz PA; Land SR; Geyer CE; Cecchini RS; Costantino JP; Pajon ER; Fehrenbacher L; Atkins JN; Polikoff JA; Vogel VG; Erban JK; Livingston RB; Perez EA; Mamounas EP; Wolmark N; Swain SM
J Clin Oncol; 2011 Mar; 29(9):1110-6. PubMed ID: 21300930
[TBL] [Abstract][Full Text] [Related]
3. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
Swain SM; Jeong JH; Geyer CE; Costantino JP; Pajon ER; Fehrenbacher L; Atkins JN; Polikoff J; Vogel VG; Erban JK; Rastogi P; Livingston RB; Perez EA; Mamounas EP; Land SR; Ganz PA; Wolmark N
N Engl J Med; 2010 Jun; 362(22):2053-65. PubMed ID: 20519679
[TBL] [Abstract][Full Text] [Related]
4. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH
World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
[TBL] [Abstract][Full Text] [Related]
6. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R
Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460
[TBL] [Abstract][Full Text] [Related]
7. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
Iwamoto T; Hara F; Uemura Y; Mukai H; Watanabe T; Ohashi Y
Breast Cancer Res Treat; 2020 Jul; 182(2):325-332. PubMed ID: 32462261
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Munster PN; Moore AP; Ismail-Khan R; Cox CE; Lacevic M; Gross-King M; Xu P; Carter WB; Minton SE
J Clin Oncol; 2012 Feb; 30(5):533-8. PubMed ID: 22231041
[TBL] [Abstract][Full Text] [Related]
9. Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.
Park IH; Han HS; Lee H; Lee KS; Kang HS; Lee S; Kim SW; Jung S; Ro J
Ann Oncol; 2012 Sep; 23(9):2283-2289. PubMed ID: 22377562
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
12. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.
Berliere M; Dalenc F; Malingret N; Vindevogel A; Piette P; Roche H; Donnez J; Symann M; Kerger J; Machiels JP
BMC Cancer; 2008 Feb; 8():56. PubMed ID: 18291033
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.
Han HS; Ro J; Lee KS; Nam BH; Seo JA; Lee DH; Lee H; Lee ES; Kang HS; Kim SW
Breast Cancer Res Treat; 2009 May; 115(2):335-42. PubMed ID: 18506620
[TBL] [Abstract][Full Text] [Related]
14. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
[TBL] [Abstract][Full Text] [Related]
15. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.
Sukumvanich P; Case LD; Van Zee K; Singletary SE; Paskett ED; Petrek JA; Naftalis E; Naughton MJ
Cancer; 2010 Jul; 116(13):3102-11. PubMed ID: 20564648
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Vehmanen L; Elomaa I; Blomqvist C; Saarto T
J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
Mackey JR; Pieńkowski T; Crown J; Sadeghi S; Martin M; Chan A; Saleh M; Sehdev S; Provencher L; Semiglazov V; Press MF; Sauter G; Lindsay M; Houé V; Buyse M; Drevot P; Hitier S; Bensfia S; Eiermann W
Ann Oncol; 2016 Jun; 27(6):1041-1047. PubMed ID: 26940688
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
[TBL] [Abstract][Full Text] [Related]
20. The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.
Jung M; Shin HJ; Rha SY; Jeung HC; Hong S; Moon YW; Kim HS; Oh KJ; Yang WI; Roh JK; Chung HC
Ann Surg Oncol; 2010 Dec; 17(12):3259-68. PubMed ID: 20563656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
